Literature DB >> 2111270

Inhibition of human and rabbit platelet activation by Ketotifen.

P Devillier1, B Arnoux, C Lalau Keraly, A Landes, J Marsac, J Benveniste.   

Abstract

The effects of Ketotifen and disodium cromoglycate were investigated on human and rabbit platelet activation. Ketotifen inhibited dose-dependently human and rabbit platelet aggregation. The paf-acether pathway was the most markedly influenced by Ketotifen in human and rabbit platelets (IC50 = 38.8 +/- 7.7 microM and 7.2 +/- 4.5 microM respectively) as compared to adenosine diphosphate (IC50 greater than 100 microM and 79 +/- 19 microM) and to arachidonic acid (IC50 greater than 100 microM and 98 +/- 28 microM). Similar concentrations of Ketotifen inhibited the ATP release from human platelets induced by paf-acether. Disodium cromoglycate up to 5 x 10(-4) M did not inhibit platelet aggregation induced by paf-acether, adenosine diphosphate and arachidonic acid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111270     DOI: 10.1111/j.1472-8206.1990.tb01011.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  4 in total

Review 1.  Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.

Authors:  S M Grant; K L Goa; A Fitton; E M Sorkin
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

2.  Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.

Authors:  M Kidd; S H McKenzie; I Steven; C Cooper; R Lanz
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

3.  Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.

Authors:  L Kahhak; A Roche; C Dubray; C Arnoux; J Benveniste
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575

Review 4.  Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications.

Authors:  Rosa M Muñoz-Cano; Rocio Casas-Saucedo; Antonio Valero Santiago; Irina Bobolea; Paula Ribó; Joaquim Mullol
Journal:  J Clin Med       Date:  2019-08-29       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.